HIGHLIGHTS
- who: Barbara J Mann and colleagues from the University of Virginia School of Medicine, Department of Medicine, Division of Infectious Diseases and International Health, Charlottesville, VA, USA have published the paper: TaffiX® Nasal Powder forms an Effective Barrier against SARS-CoV-2, in the Journal: (JOURNAL) of January/13,/2021
SUMMARY
Effective measures that reduce exposure to the SARS-CoV-2 virus are an important aspect of containing the COVID-19 pandemic. With uncertainties surrounding the emergence of new variants and vaccine protection, and evidence that presymptomatic and asymptomatic transmission of SARS-CoV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.